Location History:
- Nuremberg, DE (1993 - 1996)
- Frankfurt-am-Main, DE (2014)
- Bad Soden, DE (2008 - 2024)
Company Filing History:
3 out of 7 
3 out of 1,827 
3 out of 4,804 
Years Active: 1993-2024
Title: Gerd Geisslinger: Innovating Neuropathic Pain Treatments
Introduction: Gerd Geisslinger is a prominent inventor based in Bad Soden, Germany. With an impressive portfolio of 13 patents, he has made significant contributions to the field of pharmaceuticals, particularly in the treatment of pain. His work focuses on innovative treatments aimed at alleviating neuropathic pain, showcasing his commitment to improving patient outcomes.
Latest Patents: Gerd Geisslinger’s latest patents include two groundbreaking inventions:
1. **CYP2J2 Antagonists in the Treatment of Pain**: This invention offers novel therapeutic options for neuropathic pain, especially chemotherapy-induced peripheral neuropathic pain (CIPNP). It highlights the use of CYP2J2 antagonists to alleviate CIPNP in vivo, allowing for higher doses of chemotherapeutics during cancer treatment. Furthermore, it suggests the combination of CYP2J2 agonists and TRPV1 agonists to target disorders responsive to TRPV1 activity.
2. **N-terminally Truncated Interleukin-38**: This patent pertains to an innovative form of interleukin-38 that acts as an antagonist to immune activation in macrophages. It emphasizes the potential use of the truncated cytokine in treating and preventing autoimmune disorders, offering new therapeutic avenues for patients.
Career Highlights: Throughout his career, Gerd Geisslinger has worked with several notable organizations, including Paz Arzneimittelentwicklungsgesellschaft mbH and Sanofi-Aventis Deutschland GmbH. His experience at these companies has reinforced his expertise in drug development and innovation in the pharmaceutical industry.
Collaborations: Gerd has collaborated with esteemed professionals in the field, including Martin Michaelis and Kay Brune. Their joint efforts highlight the importance of teamwork in advancing scientific research and developing effective treatments.
Conclusion: Gerd Geisslinger stands out as a dedicated inventor whose innovations significantly impact the treatment of neuropathic pain and autoimmune disorders. His contributions through patents not only reflect his expertise but also offer hope for patients dealing with complex medical conditions. As the pharmaceutical landscape continues to evolve, Geisslinger’s work is likely to play an essential role in shaping future therapeutic strategies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.